je.st
news
Akorn Reaffirms 2015 Revenue and EPS Guidance
2015-03-10 16:40:35| Biotech - Topix.net
Akorn, Inc. reaffirms its 2015 EPS metrics issued on February 26, 2015 calling for revenue of between $960 million and $980 million and adjusted diluted earnings per share of between $1.88 and $1.98. Akorn's Chief Financial Officer Tim Dick will present at the Barclays Global Healthcare Conference on Thursday, March 12, 2015 at 10:15 a.m. EDT at the Loews Miami Beach Hotel in Miami Beach, Florida.
Tags: revenue
guidance
eps
reaffirms
Category:Biotechnology and Pharmaceuticals